Skip to results
Modify your search
NARROW
1-20 of 53
Keywords: phosphodiesterase inhibitors
Sort by
Journal Article
An overview of the history, current strategies, and potential future treatment approaches in erectile dysfunction: a comprehensive review
Get access
Mohammad Amin Langarizadeh and others
Sexual Medicine Reviews, Volume 11, Issue 3, July 2023, Pages 253–267, https://doi.org/10.1093/sxmrev/qead014
Published: 19 April 2023
... programmed clinical trials can be a big step toward solving this global problem. Graphical abstract erectile dysfunction phosphodiesterase inhibitors intracavernous injection herbal therapy nitric oxide Corresponding author: Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman...
Journal Article
Effect of phosphodiesterase type 5 inhibitors on major adverse cardiovascular events and overall mortality in a large nationwide cohort of men with erectile dysfunction and cardiovascular risk factors: A retrospective, observational study based on healthcare claims and national death index data
Robert A Kloner and others
The Journal of Sexual Medicine, Volume 20, Issue 1, January 2023, Pages 38–48, https://doi.org/10.1093/jsxmed/qdac005
Published: 13 January 2023
..., and reproduction in any medium, provided the original work is properly cited. Erectile dysfunction phosphodiesterase inhibitors cardio-protection major adverse cardiovascular events myocardial infarction Sanofi to HMRI The clinical efficacy of PDE-5is in treating ED is well known to be related...
Journal Article
A Review on Phosphodiesterase-5 Inhibitors as a Topical Therapy for Erectile Dysfunction
Get access
Mohammadsadegh Hamzehnejadi and others
Sexual Medicine Reviews, Volume 10, Issue 3, July 2022, Pages 376–391, https://doi.org/10.1016/j.sxmr.2022.02.002
Published: 01 July 2022
... and dosage forms with fewer side effects, interactions, and contraindications with maintained efficacy. Objectives 5-Phosphodiesterase inhibitors (5-PDEIs or PDE5Is), previously used systemically to treat erectile malfunction, are now appropriate candidates for topical application with considerable...
Journal Article
The Sexual Goals of Metoidioplasty Patients and Their Attitudes Toward Using PDE5 Inhibitors and Intracavernosal Injections as Erectile Aids
Amir Khorrami and others
Sexual Medicine, Volume 10, Issue 3, June 2022, Pages 1–8, https://doi.org/10.1016/j.esxm.2022.100505
Published: 08 April 2022
... surgery Metoidioplasty Phalloplasty Sexual dysfunction Erectile dysfunction Erectile Aids Phosphodiesterase inhibitors Intracavernosal injections Gender-affirming surgery is broadly categorized into top and bottom (lower) procedures. The three main reported goals of bottom surgeries for transmen...
Journal Article
Influence of Alcohol on Phosphodiesterase 5 inhibitors Use in Middle- to Old-Aged Men: A Comparative Study of Adverse Events
Jong Nyeong Kim and others
Sexual Medicine, Volume 7, Issue 4, December 2019, Pages 425–432, https://doi.org/10.1016/j.esxm.2019.07.004
Published: 20 August 2019
...% of middle- to old-age men committed concomitant use of PDE-5 inhibitor with alcohol because of recreational purpose, and this alcohol abuse might lead to severe complications, including chest discomfort and dizziness. Erectile Dysfunction Phosphodiesterase Inhibitors Alcohol Erectile dysfunction (ED...
Journal Article
Variability in Prices for Erectile Dysfunction Medications—Are All Pharmacies the Same?
Get access
Kirtishri Mishra and others
The Journal of Sexual Medicine, Volume 15, Issue 12, December 2018, Pages 1785–1791, https://doi.org/10.1016/j.jsxm.2018.10.011
Published: 01 December 2018
... affordable prices. Erectile Dysfunction Impotence Phosphodiesterase Inhibitors Drug Therapy Cost Sildenafil, the only generic PDEI available at the time of this study, is the most commonly used ED medication, and was the only medication that was available at all pharmacies. Consequently...
Journal Article
Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the Market
Get access
Robert A. Kloner and others
Sexual Medicine Reviews, Volume 6, Issue 4, October 2018, Pages 583–594, https://doi.org/10.1016/j.sxmr.2018.03.008
Published: 01 October 2018
... profile and present some encouraging signals for new CV indications, which will require additional study. Cardiovascular System Phosphodiesterase Inhibitors Erectile Dysfunction Safety For a penile erection to occur, vasodilation of the blood vessels with accompanying increased blood flow and storage...
Journal Article
EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil
Giovanni Corona and others
Sexual Medicine, Volume 6, Issue 1, March 2018, Pages 15–23, https://doi.org/10.1016/j.esxm.2017.10.003
Published: 21 December 2017
... it with their general physician. 11 Avanafil Erectile Dysfunction Survey Phosphodiesterase Inhibitors Abstract Introduction Erectile dysfunction (ED) is a multidimensional disorder with an estimated prevalence of 1% to 10% in men younger than 40 years and up to 100% in men in their 70s and 80s. Aim...
Journal Article
Off-Target Effect of Sildenafil on Postsurgical Erectile Dysfunction: Alternate Pathways and Localized Delivery System
Get access
Amirali Salmasi and others
The Journal of Sexual Medicine, Volume 13, Issue 12, December 2016, Pages 1834–1843, https://doi.org/10.1016/j.jsxm.2016.10.003
Published: 01 December 2016
... and vardenafil. Sildenafil- or rolipram-loaded NSP delivery to the site of nerve injury prevented erectile dysfunction and led to increased neurofilament, nitric oxide synthase, smooth muscle content in rat penile tissue after BCNI. Phosphodiesterase Inhibitors Cavernous Nerve Injury Iatrogenic Erectile...
Journal Article
Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications
Pim R. A. Heckman and others
International Journal of Neuropsychopharmacology, Volume 19, Issue 10, October 2016, pyw030, https://doi.org/10.1093/ijnp/pyw030
Published: 02 April 2016
... phosphodiesterase phosphodiesterase inhibitors cyclic adenosine monophosphate Abstract Background: The fronto-striatal circuits are the common neurobiological basis for neuropsychiatric disorders, including schizophrenia, Parkinson’s disease, Huntington’s disease, attention deficit hyperactivity disorder...
Journal Article
Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle
Neena Lala-Tabbert and others
Stem Cells Translational Medicine, Volume 5, Issue 4, April 2016, Pages 500–510, https://doi.org/10.5966/sctm.2015-0169
Published: 03 March 2016
... is an efficient method of expanding muscle progenitor cells, while preserving regenerative potential, before transplantation. Phosphodiesterase inhibitor treatment improves myoblast culture conditions in such a way as to reinvigorate myoblast transplantation as a viable therapeutic approach to halt muscle wasting...
Journal Article
Clinically relevant enhancement of human sperm motility using compounds with reported phosphodiesterase inhibitor activity
Steve Tardif and others
Human Reproduction, Volume 29, Issue 10, 10 October 2014, Pages 2123–2135, https://doi.org/10.1093/humrep/deu196
Published: 14 August 2014
..., and reproduction in any medium, provided the original work is properly cited. Abstract STUDY QUESTION Can we identify compound(s) with reported phosphodiesterase inhibitor (PDEI) activity that could be added to human spermatozoa in vitro to enhance their motility without compromising other sperm...
Journal Article
Nebivolol Potentiates the Efficacy of PDE5 Inhibitors to Relax Corpus Cavernosum and Penile Arteries from Diabetic Patients by Enhancing the NO/cGMP Pathway
Get access
Juan I. Martínez‐Salamanca and others
The Journal of Sexual Medicine, Volume 11, Issue 5, May 2014, Pages 1182–1192, https://doi.org/10.1111/jsm.12477
Published: 01 May 2014
... Dysfunction and Hypertensive Agents Nitric Oxide β‐Blockers Type 5 Phosphodiesterase Inhibitors Diabetes Corpus Cavernosum and Penile Arteries Abstract Introduction The efficacy of oral pharmacotherapy for erectile dysfunction (ED) (i.e., type 5 phosphodiesterase [PDE5] inhibitors) is significantly...
Journal Article
Powerful Relaxation of Phosphodiesterase Type 4 Inhibitor Rolipram in the Pig and Human Bladder Neck
Get access
Ana S.F. Ribeiro and others
The Journal of Sexual Medicine, Volume 11, Issue 4, April 2014, Pages 930–941, https://doi.org/10.1111/jsm.12456
Published: 01 April 2014
..., this relaxation also being due to neuronal NO and H2S release. Phosphodiesterase Inhibitors and Urogenital Function PDE4 Expression Rolipram PDE 4 and 5 Inhibitors PKA K+ Channels Ca2+ Signaling NO H2S Pig and Human Bladder Neck The bladder neck is part of the urine...
Journal Article
Community Pharmacy Detection of Erectile Dysfunction in Men with Risk Factors or Who Seek Treatment or Advice But Lack a Valid Prescription
Get access
Antonio Martin Morales and others
The Journal of Sexual Medicine, Volume 10, Issue 9, September 2013, Pages 2303–2311, https://doi.org/10.1111/jsm.12238
Published: 01 September 2013
... Referral and Consultation Phosphodiesterase Inhibitors Sildenafil Tadalafil Vardenafil Prescription In men who voluntarily approach a pharmacist and do not have a valid prescription for an ED medication, this study was designed to detect the potential presence of ED by the pharmacist, either...
Journal Article
Impact of a First Treatment with Phosphodiesterase Inhibitors on Men and Partners’ Quality of Sexual Life: Results of a Prospective Study in Primary Care
Get access
Pierre Costa and others
The Journal of Sexual Medicine, Volume 10, Issue 7, July 2013, Pages 1850–1860, https://doi.org/10.1111/jsm.12186
Published: 01 July 2013
... of survey: Erectile Dysfunction Self Esteem Primary Care Quality of Sexual Life Phosphodiesterase Inhibitors Couple Sexual Health Sexual health is an integral part of the physical well‐being of a person. For men, a satisfactory sexual life relies on three main components: sufficient penile rigidity...
Journal Article
The Global Online Sexuality Survey (GOSS): The United States of America in 2011 Chapter II: Phosphodiesterase Inhibitors Utilization Among English Speakers
Get access
Osama Shaeer
The Journal of Sexual Medicine, Volume 10, Issue 2, February 2013, Pages 532–540, https://doi.org/10.1111/j.1743-6109.2012.02972.x
Published: 01 February 2013
...% (Figure 4 ). Seventy‐four point two percent of recreational users purchased PDEi's from pharmacies, 16.1% over the Internet, 1.6% from both of the fore mentioned, and 8.1% from other sources. Figure 4 Recreational use of phosphodiesterase inhibitors (PDEi's). ED = erectile dysfunction; IIEF‐5...
Journal Article
SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction
Get access
Hartmut Porst and others
The Journal of Sexual Medicine, Volume 10, Issue 1, January 2013, Pages 130–171, https://doi.org/10.1111/jsm.12023
Published: 01 January 2013
... and dapoxetine is effective and safe in patients suffering from both ED and premature ejaculation. Erectile Dysfunction Oral Drug Treatment Phosphodiesterase Inhibitors Intracavernous Self-Injection Therapy Transurethral Alprostadil Therapy Combination Therapies Vacuum Device Therapy Sexuality is a key...
Journal Article
Cyclic AMP Dysregulates Intestinal Epithelial Cell Restitution Through PKA and RhoA
Get access
Noah P. Zimmerman and others
Inflammatory Bowel Diseases, Volume 18, Issue 6, 1 June 2012, Pages 1081–1091, https://doi.org/10.1002/ibd.21898
Published: 12 October 2011
... that treatment with cAMP-elevating agents severely limits mucosal reepithelialization and should be contraindicated for use in chronic inflammatory bowel disorders. cAMP PKA restitution intestinal epithelium phosphodiesterase inhibitors Intestinal epithelial cells form a barrier and regulate secretion...
Journal Article
Are Phosphodiesterase Type 5 Inhibitors Associated with Vision‐Threatening Adverse Events? A Critical Analysis and Review of the Literature
Get access
F. Azzouni and K. Abu samra
The Journal of Sexual Medicine, Volume 8, Issue 10, October 2011, Pages 2894–2903, https://doi.org/10.1111/j.1743-6109.2011.02382.x
Published: 01 October 2011
...% of users and they are transient and reversible. Sildenafil Tadalafil Vardenafil Ocular Complications Phosphodiesterase Inhibitors Erectile Dysfunction Viagra and Eye Since these medications are widely used for the treatment of erectile dysfunction, benign prostate hyperplasia [34...
Advertisement
Advertisement